Challenges in Medical Retina and Diabetes

My Session Status

When:

3:45 PM, Sunday 3 Jun 2018 (1 hour 30 minutes)

Where:

Metro Toronto Convention Centre (South Building) - Room 803

Theme:

Retina

LEARNING OBJECTIVES
After this session, participants will be able to:

Assess how tomographic and clinical findings from multi-modal imaging techniques in neovascular AMD and diabetic retinopathy can affect visual outcomes
Describe the predictability of different intraocular cytokines to response to intravitreous anti-VEGF therapy in diabetic macular edema

CANMEDS ROLES: Health Advocate, Medical Expert

Varun Chaudhary

Moderator

Peter Kertes

Moderator

Sub Sessions

Introduction

3:45 PM - 3:50 PM | 5 minutes

Multifocal electroretinographic changes after cessation of plaquenil therapy for suspected toxicity

3:50 PM - 4:00 PM | 10 minutes

Authors: Beatrice Adamptey, Chris Rudnisky, Ian M. MacDonald Author Disclosure Block: B. Adamptey: None. C. Rudnisky: None. I.M. MacDonald: None. Abstract Body: Purpose: To describe multifocal electroretinogram (mfERG) changes among patients suspected to show hydroxychloroquine (Plaquenil) toxicity and their outcomes after discontinuation of Plaquenil therapy. Study Design: A retrospective case series of 14 patients followe...

Beatrice Adamptey MD

Participant

Canadian treat and extend analysis trial with ranibizumab in patients with neovascular AMD: CANTREAT study one year results

4:00 PM - 4:10 PM | 10 minutes

Authors: Peter Kertes, Tom Sheidow, Geoff Williams, Mark Greve, Ivan Galic, Emmanouil Rampakakis, Joanne Gavalakis, Andrea Scarino Author Disclosure Block: P. Kertes: Grant/research support; Novartis, Bayer. Major stock shareholder; Arctic Dx.. Membership on an advisory panel, standing committee or board of directors; Novartis, Bayer, Alcon. T. Sheidow: Membership on an advisory panel, standing committee or board of directors; Novartis, Bayer, Alcon. G. Williams: Membership ...

Peter Kertes

Participant

Prevalence of obstructive sleep apnea in patients with retinal vein occlusion

4:10 PM - 4:20 PM | 10 minutes

Authors: Michael H. Brent, Tina Felfeli, Efrem D. Mandelcorn, Colin Shapiro, Roy Alon Author Disclosure Block: M. Brent: Grant/research support; Novartis, Allergan, Bayer, Roche. Membership on an advisory panel, standing committee or board of directors; Novartis, Bayer, Allergan, Alcon. T. Felfeli: None. E. Mandelcorn: Employment/honoraria/consulting fees; Novartis, Bayer, Optos, Bausch & Lomb. C. Shapiro: None. R. Alon: None. Abstract Body: Pur...

Michael Brent MD

Participant

The association of aqueous cytokines with long-term response to intravitreal ranibizumab in diabetic macular edema

4:20 PM - 4:30 PM | 10 minutes

Authors: Tina Felfeli, Verena Juncal, Roxane J. Hillier, Elvis Ojaimi, David T. Wong, Michael Y. K. Mak, Alan R. Berger, Radha P. Kohly, Peter J. Kertes, Farzin Forooghian, Shelley R. Boyd, Filiberto Altomare, Louis R. Giavedoni, Rosane Nisenbaum, Rajeev H. Muni Author Disclosure Block: T. Felfeli: None. V. Juncal: None. R.J. Hillier: None. E. Ojaimi: None. D.T. Wong: None. M.Y.K. Mak: None. A.R. Berger: None. R.P. Kohly: None. P.J. Kertes: None. F. Forooghian: None. ...

Dr. Verena Juncal

Participant

Time to treatment - A tele-retinal referral system for wet age-related macular degeneration and diabetic macular edema